HDFC Pharma and Healthcare Fund

How are the returns of HDFC Pharma and Healthcare Fund calculated?

All return figures on this page are derived from official NAV data published by AMFI India, updated every trading day. The 1-day return compares the most recent NAV with the previous trading day's NAV. Returns for 3 months, 6 months and 1 year are simple point-to-point percentage changes. For periods of 2 years and beyond, returns are expressed as CAGR — Compound Annual Growth Rate — which accounts for compounding and gives a more accurate picture of annual wealth creation.

The best and worst 1-year ever figures scan every possible rolling 12-month window in the fund's history to find the highest and lowest return. This is far more useful than a single snapshot because it shows the actual range of outcomes across all market conditions — bull markets, corrections and recoveries — that real investors in this fund have experienced.

All data is for the Regular Plan, Growth option. This is the plan most investors hold when investing through a mutual fund distributor. See all funds at mutual fund returns.

What does the 52-week high and low tell you about HDFC Pharma and Healthcare Fund?

The 52-week high is the highest NAV this fund has reached in the past 365 days and the 52-week low is the lowest. The distance between the current NAV and the 52-week high — shown as "vs 52W High" — tells you how much the fund has pulled back from its recent peak. A fund trading close to its 52-week high is showing strong recent momentum; one sitting far below it has seen a notable correction.

The all-time high and low extend this view across the fund's entire life since launch. The "vs ATH" figure tells you how far below its lifetime peak the fund is currently trading. For long-term investors, this context is more meaningful than any single calendar-year return because it shows where the fund stands relative to its own complete history.

These levels are recalculated every trading day after AMFI publishes NAV data, so the dates and distances you see reflect the most current available information.

How should you read the peer comparison for HDFC Pharma and Healthcare Fund?

The peer comparison shows the top 10 funds in the Sectoral/Thematic category sorted by 1-year return. This tells you at a glance how HDFC Pharma and Healthcare Fund ranks within its peer group across multiple time horizons. A fund consistently in the upper half of its category across 1Y, 3Y and 5Y columns is demonstrating durable performance rather than a single-year spike driven by sector timing.

When evaluating any fund against its peers, give more weight to the 3Y and 5Y CAGR columns than to 1-year figures. A strong 1-year return can simply reflect a sector tailwind — for example, all small cap funds doing well during a broader market rally — while 3Y and 5Y performance across different market cycles is a better indicator of consistent fund management quality.

All peer comparison figures are for regular growth plans only, sourced from AMFI NAV data and updated daily. Clicking any fund in the peer table will open that fund's detail page.

What does the category ranking of HDFC Pharma and Healthcare Fund mean?

The category ranking shows where HDFC Pharma and Healthcare Fund stands relative to all other active regular plan funds in the Sectoral/Thematic category, based on 1-year, 3-year and 5-year returns. A rank of #5 out of 37 funds means this fund has delivered better returns than 32 of its peers over that period. The ranking is colour-coded — green for top third, gold for middle third, red for bottom third — giving an instant sense of where the fund sits within its competitive landscape.

It is important to read the ranking in context of the time period. A fund can rank highly on 1-year returns due to a short-term sector tailwind while sitting in the middle on 3-year and 5-year CAGR, which reflects more durable performance. The most reliable funds are those that maintain a consistent position in the upper half of their category across multiple time periods rather than spiking briefly at the top.

The total number of funds shown in the ranking reflects only active regular growth plans in the Sectoral/Thematic category as tracked by CRN India. The count may differ slightly from AMFI's total scheme count because inactive, wound-up or segregated portfolio funds are excluded.

How consistent has HDFC Pharma and Healthcare Fund been year after year?

The consistency score shows how many calendar years since 2016 the fund has delivered a positive return. A score of 7 out of 9 years means the fund ended seven of the nine calendar years with gains — a strong indicator of resilience across different market conditions including corrections, sideways markets and strong rallies. A fund that is consistently positive across most years is generally more reliable than one with extreme highs and lows even if the average return is similar.

The category rank by year table shows not just whether the fund was positive, but exactly where it ranked within its Sectoral/Thematic category peers for each calendar year. A fund that consistently finishes in the top half of its category year after year — even in difficult years — is demonstrating the kind of steady outperformance that long-term compounding rewards. A fund that tops the rankings in bull years but falls to the bottom in corrections may be taking concentrated risks that its category ranking does not reveal.

The 52-week position gauge shows where the current NAV sits within its one-year trading range. A fund near its 52-week high is showing strong recent momentum. A fund near its 52-week low may be going through a correction or sector-specific stress. Neither position is inherently good or bad — it depends on the fund's fundamentals and the investor's time horizon. See all Sectoral/Thematic funds ranked by return on the top Sectoral/Thematic regular funds page.